Navigating the Labyrinth of Private Equity Investments in Health Care – Diagnosing Health Care
HHS Office for Civil Rights Director Melanie Fontes Rainer on Progress and News at OCR
ERISA Blog | Changes to the HIPAA Privacy Rules A Primer for Self-Insured Group Health Plans
Hospice Insights Podcast - A Refresh: What’s New in the New OIG General Compliance Program Guidance
The Presumption of Innocence Podcast: Special Edition | Episode 36 - Rolling Change: The DEA Turns Over a New Leaf on Marijuana Scheduling
Understanding the HHS OIG’s General Compliance Program Guidance
OMG. . .The OIG is at it Again
The FTC's Health Privacy Enforcement Actions
Medical Device Legal News with Sam Bernstein: Episode 19
Episode 303 --- Deep Dive into the HHS-OIG Compliance Program Guidance
Counsel That Cares - The Private Payer's Perspective on Value-Based Care
Medical Device Legal News with Sam Bernstein: Episode 17
Podcast - Data Privacy and Tracking Technology Compliance
Podcast - A Conversation on Cannabis: Are Challenges or Changes Coming?
Heed Caution: Takeaways From the OIG's Advance Care Planning Report
2023 Human Resources Outlook Podcast Series: EMEA
Telehealth Risk Report: What the Government Found
UPIC Report Card: The OIG’s Evaluation of the UPICs Provides Insight Into the Future of Hospice Audits
HIPAA Tips With Williams Mullen - Telehealth After the Pandemic
Beyond Hospice: The OIG Renews Its Scrutiny of Home Health Agencies
Earlier this week, the Department of Justice proposed reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act. The move follows an August 2023 recommendation from the Department of Health...more
In October of 2022, the Biden Administration started an official cannabis policy review process, which began with granting pardons to all people convicted of simple cannabis possession under federal law. At the time, this was...more
*Wiley continues to closely monitor the COVID-19 crisis and will update this list as new information is available. This alert was originally published on March 25, 2020, and last updated February 12, 2021. ...more
*Wiley continues to closely monitor the COVID-19 crisis and will update this list as new information is available. This alert was originally published on March 25, 2020, and last updated January 20, 2021. ...more
*Wiley continues to closely monitor the COVID-19 crisis and will update this list as new information is available. This alert was originally published on March 25, 2020, and last updated January 4, 2021. ...more
On December 18, 2020, just three days after the U.S. Senate adopted the Cannabidiol and Marihuana Research Expansion Act (CMREA or the Act) (more on this below), the U.S. Drug Enforcement Administration (DEA or the...more
*Wiley continues to closely monitor the COVID-19 crisis and will update this list as new information is available. This alert was originally published on March 25, 2020, and last updated December 18, 2020. ...more
*Wiley continues to closely monitor the COVID-19 crisis and will update this list as new information is available. This alert was originally published on March 25, 2020, and last updated December 4, 2020. ...more
*Wiley continues to closely monitor the COVID-19 crisis and will update this list as new information is available. This alert was originally published on March 25, 2020, and last updated November 13, 2020....more
*Wiley continues to closely monitor the COVID-19 crisis and will update this list as new information is available. This alert was originally published on March 25, 2020, and last updated October 9, 2020. 1. Administration...more
Report on Research Compliance 17, no. 1 (January 2020) - ? A man from Richland, Washington, is facing life in prison after being convicted of 47 counts of fraud for staging clinical trials that purportedly enrolled dozens of...more